Clinical Laboratory Improvement Advisory Committee (CLIAC); Cancellation of Meeting

• Published date: 25 March 2020
• Citation: 85 FR 16945
• Record Number: 2020-06249
• Section: Notices
• Court: Centers For Disease Control And Prevention

Federal Register, Volume 85 Issue 58 (Wednesday, March 25, 2020)

[Federal Register Volume 85, Number 58 (Wednesday, March 25, 2020)]
                [Notices]
                [Page 16945]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-06249]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Centers for Disease Control and Prevention
                Clinical Laboratory Improvement Advisory Committee (CLIAC);
                Cancellation of Meeting
                 Notice is hereby given of a change in the meeting of the Clinical
                Laboratory Improvement Advisory Committee (CLIAC); April 16, 2020, 8:30
                a.m. to 5:00 p.m., EDT and April 17, 2020, 8:30 a.m. to 11:30 a.m.,
                EDT, in the original FRN. Food and Drug Administration (FDA), White Oak
                Campus, 10903 New Hampshire Avenue, Building 31, Great Room, Silver
                Spring, Maryland 20993 and via webcast at www.cdc.gov/cliac which was
                published in the Federal Register on February 28, 2020, Volume 85,
                Number 40, page 11993.
                 This meeting is being canceled in its entirety.
                FOR FURTHER INFORMATION CONTACT: Nancy Anderson, MMSc, MT(ASCP), Senior
                Advisor for Clinical Laboratories, Division of Laboratory Systems,
                Center for Surveillance, Epidemiology and Laboratory Services, Office
                of Public Health Scientific Services, Centers for Disease Control and
                Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia
                30329-4027, telephone (404) 498-2741; [email protected].
                 The Director, Strategic Business Initiatives Unit, Office of the
                Chief Operating Officer, Centers for Disease Control and Prevention,
                has been delegated the authority to sign Federal Register notices
                pertaining to announcements of meetings and other committee management
                activities, for both the Centers for Disease Control and Prevention and
                the Agency for Toxic Substances and Disease Registry.
                Kalwant Smagh,
                Director, Strategic Business Initiatives Unit, Office of the Chief
                Operating Officer, Centers for Disease Control and Prevention.
                [FR Doc. 2020-06249 Filed 3-24-20; 8:45 am]
                BILLING CODE 4163-18-P